PTCT missed EPS expectations by 102.29%
Feb 20, 2026, 11:34 AM
0.00%
What does PTCT do
PTC Therapeutics, headquartered in Warren, New Jersey, develops medicines for rare disorders and has two key products for Duchenne muscular dystrophy. The company went public in 2013 and employs 988 people.
PTC Therapeutics (PTCT) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, PTC Therapeutics's actual EPS was -$1.67, missing the estimate of $0.04 per share, resulting in a -102.29% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.